The Journal of Clinical Psychiatry · 2002 · 88 citations · 3 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAnxiety Disorder PharmacotherapyAnxiety DisordersAnxiety ManagementAnxiolytic PharmacotherapyAnxiolytic TherapySerotonergic PharmacologyAnxiolytic Medication UseAnxiolytic MedicationsBenzodiazepine TreatmentDependence PotentialPharmacological Anxiety ManagementPharmacology Of Serotonergic AgentsTreatment Of Anxiety Disorders
Article AbstractModern guidelines for psychopharmacologic treatment of anxiety disorders have evolved from recommending GABAergic (gammaaminobutryic acid) benzodiazepines to recommending serotonergic agents for first-line use. This trend, along with adverse publicity about the dependence potential of benzodiazepines, might lead one to suspect that benzodiazepines, once prominent in the 1980s but now generic and often disparaged, must have significantly declined in use. Not so. In fact, benzodiazepines are still more widely prescribed than antidepressants for the treatment of anxiety disorders (Table 1), and alprazolam is the single most commonly prescribed agent for mood and anxiety disorders(Table 2).
3
Venlafaxine XR in the treatment of anxiety
D. Hackett · Acta Psychiatrica Scandinavica · 2000 · 177 citations
Medicine, Pharmacology, Psychiatry +17
Early Coadministration of Clonazepam With Sertraline for Panic Disorder
Andrew W. Goddard, Thomas Brouette, Ahmad Almai et al. · Archives of General Psychiatry · 2001 · 159 citations